INZY

Inozyme Pharma
INZY

Overview Fund Activity
Delisted

INZY was delisted on the 30th of June, 2025.

Back to rankings

39 hedge funds and large institutions have $84.6M invested in Inozyme Pharma in 2022 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 12 increasing their positions, 14 reducing their positions, and 10 closing their positions.

Holders
39
Holders Change
-8
Holders Change %
-17.02%
% of All Funds
0.67%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
2
Increased
12
Reduced
14
Closed
10
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Janus Henderson Group
1
Janus Henderson Group
United Kingdom
$3.81M
2
RSCM
2
Rock Springs Capital Management
Maryland
$7.52M
3
Adage Capital Partners
3
Adage Capital Partners
Massachusetts
$6.96M
4
BCM
4
Bridgeway Capital Management
Texas
$358K
5
Renaissance Technologies
5
Renaissance Technologies
New York
$416K

Top Sellers

1
DM
1
Deerfield Management
New York
$5.6M
2
BBA
2
Baker Bros. Advisors
New York
$0
3
E
3
Ergoteles
New York
$0
4
CA
4
CHI Advisors
New York
$5.35M
5
Goldman Sachs
5
Goldman Sachs
New York
$0
Name Market Value Shares Shares
Change 		Shares
Change %
SI
1
Sofinnova Investments
California
$9.8M 3,655,308 – –
DTC
2
Deep Track Capital
Connecticut
$8.71M 3,250,000 – –
RSCM
3
Rock Springs Capital Management
Maryland
$7.52M 2,807,618 +167,562 +6%
VA
4
VR Adviser
New York
$7.26M 2,709,987 – –
PBPIA
5
Pivotal bioVenture Partners Investment Advisor
California
$7.13M 2,661,154 – –
Adage Capital Partners
6
Adage Capital Partners
Massachusetts
$6.96M 2,596,672 +50,000 +2%
NMC
7
NEA Management Company
Maryland
$6.55M 2,444,379 – –
DM
8
Deerfield Management
New York
$5.6M 2,090,436 -605,936 -22%
CA
9
CHI Advisors
New York
$5.35M 1,996,277 -37,525 -2%
Janus Henderson Group
10
Janus Henderson Group
United Kingdom
$3.81M 1,411,154 +481,198 +52%
Vanguard Group
11
Vanguard Group
Pennsylvania
$3.6M 1,343,063 -11,153 -0.8%
SFM
12
Sphera Funds Management
Israel
$3.15M 1,175,058 +9,458 +0.8%
MB
13
MPM BioImpact
Massachusetts
$1.77M 661,144 -3,836 -0.6%
Fidelity Investments
14
Fidelity Investments
Massachusetts
$1.63M 609,380 -439 -0.1%
BlackRock
15
BlackRock
New York
$1.15M 428,431 -2,089 -0.5%
LCM
16
Laurion Capital Management
New York
$728K 271,800 – –
Geode Capital Management
17
Geode Capital Management
Massachusetts
$626K 233,685 +16,760 +8%
Millennium Management
18
Millennium Management
New York
$456K 170,184 -2,908 -2%
UOC
19
UBS O'Connor
Illinois
$444K 165,498 -5,849 -3%
Renaissance Technologies
20
Renaissance Technologies
New York
$416K 155,400 +37,100 +31%
BCM
21
Bridgeway Capital Management
Texas
$358K 133,400 +46,000 +53%
Walleye Capital
22
Walleye Capital
New York
$315K 117,529 +16,087 +16%
Citadel Advisors
23
Citadel Advisors
Florida
$297K 110,648 -10,179 -8%
State Street
24
State Street
Massachusetts
$205K 76,355 +27,300 +56%
OMC
25
Overbrook Management Corp
New York
$186K 69,326 – –
1
2